Phototherapies for Psoriasis Market Summary

Phototherapies For Psoriasis Market and Epidemiology Analysis

• The Phototherapies for Psoriasis Market is expected to strengthen as awareness of the disease increases and more effective interventions are being developed.
• The leading Phototherapies for Psoriasis Companies in the Market such as Amgen, Pfizer, UCB Pharma, NeoStrata Company Inc, Astellas Pharma Inc, Philips Company, Abbott, Bausch Health Americas Inc., and others.

Request for unlocking the CAGR of the Phototherapies for Psoriasis Treatment Market

Factors Impacting the Phototherapies for Psoriasis Market Growth

• Sustained Clinical Relevance in Treatment Algorithms

Phototherapy continues to hold a well-established position in psoriasis management guidelines, particularly for moderate-to-severe disease, ensuring consistent utilization despite the availability of advanced systemic therapies.

• Rising Concerns Over Long-Term Safety of Systemic Therapies

Safety concerns related to prolonged use of biologics and oral immunosuppressants are encouraging clinicians and patients to opt for phototherapy as a safer, localized, and non-systemic alternative.

• Expansion of Home-Based Phototherapy Solutions

Increasing adoption of home phototherapy devices is improving treatment accessibility, reducing dependency on hospital visits, and supporting long-term disease control, thereby expanding the addressable patient pool.

• Technological Improvements Enhancing Treatment Precision

Advances in targeted phototherapy systems, including excimer lasers and narrowband UVB devices, have improved efficacy while minimizing exposure to unaffected skin, strengthening physician confidence and patient acceptance.

• Growing Psoriasis Patient Population and Earlier Diagnosis

Improved disease awareness and higher diagnosis rates are increasing the number of eligible patients for phototherapy, directly contributing to market expansion.

• Cost-Effectiveness Compared to Biologic Therapies

Phototherapy offers a comparatively lower treatment cost than biologics, making it an attractive option in cost-sensitive markets and healthcare systems with budget constraints.

• Rising Adoption in Combination Treatment Strategies

Increasing use of phototherapy alongside topical and systemic agents to enhance outcomes and reduce drug burden is reinforcing its demand across multiple lines of therapy.

• Improved Infrastructure in Dermatology Clinics

Growing investments in dermatology-focused healthcare facilities and wider availability of phototherapy units in hospitals and specialty clinics are further supporting market growth.

DelveInsight's "Phototherapies for Psoriasis Market Insights, Epidemiology, and Market Forecast-2034" report delivers an in-depth understanding of the Phototherapies for Psoriasis, historical and forecasted epidemiology as well as the Phototherapies for Psoriasis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

The Phototherapies for Psoriasis Treatment Market report provides current treatment practices, emerging drugs, Phototherapies for Psoriasis market share of the individual therapies, current and forecasted Phototherapies for Psoriasis market Size from 2020 to 2034 segmented by seven major markets. The Report also covers current Phototherapies for Psoriasis treatment market practice/algorithm, Phototherapies for Psoriasis market drivers and market barriers, and Phototherapies for Psoriasis unmet needs to curate the best of the opportunities and assesses the underlying potential of the Phototherapies for Psoriasis market.

Phototherapies for Psoriasis Understanding

The Phototherapies for Psoriasis treatment market has seen significant growth and innovation in recent years. Phototherapy, also known as light therapy, involves the use of ultraviolet (UV) light to slow down the rapid growth of skin cells that occurs in psoriasis. This non-invasive and highly effective treatment method has become increasingly popular due to its ability to provide relief from psoriasis symptoms, including redness, itching, and inflammation. Advancements in technology have led to the development of targeted phototherapy devices, enabling precise treatment of affected areas while minimizing exposure to healthy skin. The Phototherapies for Psoriasis treatment market is witnessing a surge in research and development activities aimed at enhancing the efficacy and safety of phototherapies, driving the overall market growth.

Moreover, the rising Psoriasis Prevalence globally and the growing awareness about available treatment options are contributing to the expansion of the phototherapies for psoriasis treatment market. The DelveInsight’s Phototherapies for Psoriasis market report gives a thorough understanding of the Phototherapies for Psoriasis by including details such as disease definition, symptoms, causes, pathophysiology, diagnosis, and treatment.

Phototherapies for Psoriasis Diagnosis

This segment of the report covers the detailed diagnostic methods or tests for Phototherapies for Psoriasis.

Phototherapies for Psoriasis Treatment

Phototherapy is a treatment approach for psoriasis that involves exposing the skin to specific wavelengths of light. It can be an effective treatment option for various types of psoriasis, including plaque psoriasis, guttate psoriasis, and inverse psoriasis. It covers the details of conventional and current medical therapies available in the Phototherapies for Psoriasis market for the treatment of the condition. It also provides Phototherapies for Psoriasis treatment algorithms and guidelines in the United States, Europe, and Japan.

Phototherapies for Psoriasis Epidemiology

The Phototherapies for Psoriasis epidemiology section provides insights into the historical and current Phototherapies for Psoriasis patient pool and forecasted trends for individual seven major countries. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. This part of the Phototherapies for Psoriasis market report also provides the diagnosed patient pool and their trends, along with assumptions undertaken. 

Key Findings from the Phototherapies For Psoriasis Epidemiological Analysis

The Phototherapies for Psoriasis epidemiology covered in the report provides historical as well as forecasted Phototherapies for Psoriasis Prevalence scenario in the 7MM covering the United States, EU5 countries (Germany, Spain, Italy, France, and the United Kingdom), and Japan from 2020 to 2034.

Country Wise- Phototherapies for Psoriasis Epidemiology

The Phototherapies for Psoriasis epidemiology segment also provides the Phototherapies for Psoriasis epidemiology data and findings across the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan.

Phototherapies For Psoriasis Market Recent Developments and Breakthroughs

• In December 2025, the University of Szeged initiated a study to evaluate the clinical performance of the PALLAS laser in treating UV-responsive skin conditions, including vitiligo, psoriasis, alopecia areata, and atopic dermatitis. The secondary objective of the study is to assess the user-friendliness of the PALLAS laser in routine dermatological practice. Patients enrolled in the trial will receive UVB laser therapy twice per week for up to three months, with treatments administered by physicians participating in the study. Each treatment session lasts approximately 10 minutes, and the total treatment period may extend to three months per patient. Photographic documentation of both the target lesions and treated areas will be taken at baseline and then monthly throughout the study to monitor treatment response. At the end of the study, patients will evaluate their treatment experience and clinical improvement using a Patient Satisfaction Scale.

Phototherapies for Psoriasis Drugs Analysis

The drug chapter segment of the Phototherapies for Psoriasis Treatment Market report encloses a detailed analysis of Phototherapies for Psoriasis marketed drugs and late-stage (Phase-III and Phase-II) Phototherapies for Psoriasis pipeline drugs analysis. It also helps to understand the Phototherapies for Psoriasis clinical trials details, expressive pharmacological action, agreements and collaborations, approval and patent details, advantages and disadvantages of each included drug and the latest news and press releases.

Phototherapies for Psoriasis Marketed Drugs

The Phototherapies for Psoriasis Treatment Market provides the details of the marketed products/off-label treatments available for Phototherapies for Psoriasis treatment.

Phototherapies for Psoriasis Emerging Drugs

The Phototherapies for Psoriasis Treatment Market provides the details of the emerging therapies under the late and mid-stage of development for Phototherapies for Psoriasis treatment.

Phototherapies for Psoriasis Market Outlook

The Phototherapies for Psoriasis market outlook of the report helps to build a detailed comprehension of the historic, current and forecasted Phototherapies for Psoriasis market trends by analyzing the impact of current Phototherapies for Psoriasis therapies on the market, unmet needs, drivers and barriers, and demand for better technology.

This segment gives a thorough detail of Phototherapies for Psoriasis market trend of each marketed drug and late-stage pipeline therapy by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria's, mechanism of action, compliance rate, growing need of the market, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, brand value, their impact on the market and view of the key opinion leaders. The calculated Phototherapies for Psoriasis market outlook data are presented with relevant tables and graphs to give a clear view of the market at first sight.

"According to DelveInsight, the Phototherapies for Psoriasis Treatment Market Size in 7MM is expected to witness a major change in the study period 2020-2034"

Key Findings

This section includes a glimpse of the Phototherapies for Psoriasis therapeutics market in 7MM.

The United States Phototherapies for Psoriasis Market Outlook

This section provides the total Phototherapies for Psoriasis market size and market size by therapies in the United States.

EU-5 Countries: Phototherapies for Psoriasis Market Outlook

The total Phototherapies for Psoriasis market size and market size by therapies in Germany, France, Italy, Spain, and the United Kingdom is provided in this section.

Japan Phototherapies for Psoriasis Market Outlook

The total Phototherapies for Psoriasis market size and market size by therapies in Japan is also mentioned.

Phototherapies For Psoriasis Competitive Intelligence Analysis

We perform Competitive and Market Intelligence analysis of the Phototherapies for Psoriasis Market by using various Competitive Intelligence tools that include - SWOT analysis, PESTLE analysis, Porter's five forces, BCG Matrix, Market entry strategies etc. The inclusion of the analysis entirely depends upon the data availability.

Phototherapies for Psoriasis Drugs Uptake

This section focuses on the rate of uptake of the potential Phototherapies for Psoriasis drugs recently launched in the Phototherapies for Psoriasis market or expected to get launched in the market during the study period 2020-2034. The analysis covers Phototherapies for Psoriasis market uptake by drugs; patient uptake by therapies; and sales of each drug. Phototherapies for Psoriasis Drugs Uptake helps in understanding the drugs with the most rapid uptake, the reasons behind the maximal use of new Phototherapies for Psoriasis drugs, and allows the comparison of the drugs on the basis of Phototherapies for Psoriasis market share and size which again will be useful in investigating factors important in market uptake and in making financial and regulatory decisions.

Phototherapies for Psoriasis Pipeline Development Activities

The Phototherapies for Psoriasis therapeutics market report provides insights into different therapeutic candidates in Phase II, and Phase III stage. It also analyses Phototherapies for Psoriasis Companies involved in developing targeted therapeutics. The Phototherapies for Psoriasis pipeline segment covers the detailed information of collaborations, acquisition, and merger, licensing, patent details, and other information for Phototherapies for Psoriasis emerging therapies.

Latest KOL- Views on Phototherapies for Psoriasis

To keep up with current Phototherapies for Psoriasis market trends, we take KOLs and SMEs ' opinion working in the Phototherapies for Psoriasis domain through primary research to fill the data gaps and validate our secondary research. Their opinion helps to understand and validate current and emerging therapies treatment patterns or Phototherapies for Psoriasis market trends. This will support the clients in potential upcoming novel treatment by identifying the overall scenario of the market and the unmet needs.

Phototherapies For Psoriasis Reimbursement Scenario

Approaching reimbursement proactively can have a positive impact both during the late stages of product development and well after product launch. In a report, we take reimbursement into consideration to identify economically attractive indications and market opportunities. When working with finite resources, the ability to select the markets with the fewest reimbursement barriers can be a critical business and price strategy.

Phototherapies for Psoriasis Treatment Market Report Scope

• The Phototherapies for Psoriasis Treatment Market report covers the descriptive overview of Phototherapies for Psoriasis, explaining its causes, signs and symptoms, pathophysiology, diagnosis and currently available therapies
• Comprehensive insight has been provided into the Phototherapies for Psoriasis epidemiology and treatment in the 7MM
• Additionally, an all-inclusive account of both the current and emerging therapies for Phototherapies for Psoriasis is provided, along with the assessment of new therapies, which will have an impact on the current treatment landscape
• A detailed review of the Phototherapies for Psoriasis Treatment Market; historical and forecasted is included in the report, covering drug outreach in the 7MM
• The patient-based Phototherapies for Psoriasis market forecasting report provides an edge while developing business strategies, by understanding trends shaping and driving the global Phototherapies for Psoriasis market

Phototherapies for Psoriasis Treatment Market Report Highlights

• In the coming years, the Phototherapies for Psoriasis market is set to change due to the rising awareness of the disease, and incremental healthcare spending across the world; which would expand the size of the market to enable the drug manufacturers to penetrate more into the market
• The Phototherapies for Psoriasis Companies and academics are working to assess challenges and seek opportunities that could influence Phototherapies for Psoriasis R&D. The Phototherapies for Psoriasis emerging therapies under development are focused on novel approaches to treat/improve the disease condition      
• Major Phototherapies for Psoriasis Companies are involved in developing therapies for Phototherapies for Psoriasis. The launch of emerging therapies will significantly impact the Phototherapies for Psoriasis market
• A better understanding of disease pathogenesis will also contribute to the development of novel therapeutics for Phototherapies for Psoriasis
• Our in-depth analysis of the pipeline assets across different stages of development (Phase III and Phase II), different emerging trends and comparative analysis of pipeline products with detailed clinical profiles, key cross-competition, launch date along with product development activities will support the clients in the decision-making process regarding their therapeutic portfolio by identifying the overall scenario of the research and development activities

Phototherapies for Psoriasis Market Forecast Report Insights

• Patient-based Phototherapies for Psoriasis Market Forecasting
• Therapeutic Approaches
• Phototherapies for Psoriasis Pipeline Drugs Analysis
• Phototherapies for Psoriasis Market Size
• Phototherapies for Psoriasis Market Trends
• Phototherapies for Psoriasis Drugs Market Opportunities
• Impact of Upcoming Phototherapies for Psoriasis Therapies

Phototherapies for Psoriasis Therapeutics Market Report Key Strengths

• 10 Years- Phototherapies for Psoriasis Market Forecast
• 7MM Coverage
• Phototherapies for Psoriasis Epidemiology Segmentation
• Key Cross Competition
• Highly Analyzed Phototherapies for Psoriasis Drugs Market
• Phototherapies for Psoriasis Pipeline Drugs Uptake

Phototherapies for Psoriasis Market Report Assessment

• Current Phototherapies for Psoriasis Treatment Market Practices
• Phototherapies for Psoriasis Unmet Needs
• Phototherapies for Psoriasis Pipeline Drugs Analysis Profiles
• Phototherapies for Psoriasis Drugs Market Attractiveness
• Phototherapies for Psoriasis Market Drivers
• Phototherapies for Psoriasis Market Barriers

Key Questions covered in Phototherapies for Psoriasis Market Report

Phototherapies for Psoriasis Treatment Market Insights

• What was the Phototherapies for Psoriasis drugs market share (%) distribution in 2020 and how it would look like in 2034?
• What would be the Phototherapies for Psoriasis treatment market size as well as market size by therapies across the 7MM during the forecast period (2024-2034)?
• What are the key findings pertaining to the market across 7MM and which country will have the largest Phototherapies for Psoriasis market size during the forecast period (2024-2034)?
• At what CAGR, the Phototherapies for Psoriasis market is expected to grow by 7MM during the forecast period (2024-2034)?
• What would be the Phototherapies for Psoriasis market outlook across the 7MM during the forecast period (2024-2034)?
• What would be the Phototherapies for Psoriasis market growth till 2034, and what will be the resultant market Size in the year 2034?
• How would the unmet needs affect the market dynamics and subsequent analysis of the associated trends?

Phototherapies for Psoriasis Epidemiology Insights

• What are the disease risk, burden, and regional/ethnic differences of the Phototherapies for Psoriasis?
• What are the key factors driving the epidemiology trend for seven major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK), and Japan?
• What is the historical Phototherapies for Psoriasis patient pool in seven major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK), and Japan?
• What would be the forecasted patient pool of Phototherapies for Psoriasis in seven major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK), and Japan?
• Where will be the growth opportunities in the 7MM with respect to the patient population pertaining to Phototherapies for Psoriasis?
• Out of all 7MM countries, which country would have the highest prevalent population of Phototherapies for Psoriasis during the forecast period (2024-2034)?
• At what CAGR the patient population is expected to grow in 7MM during the forecast period (2024-2034)?

Current Phototherapies for Psoriasis Treatment Market Scenario, Marketed Drugs and Emerging Therapies

• What are the current options for the Phototherapies for Psoriasis treatment in addition to the approved therapies?
• What are the current treatment guidelines for the treatment of Phototherapies for Psoriasis in the USA, Europe, and Japan?
• What are the Phototherapies for Psoriasis marketed drugs and their respective Phototherapies for Psoriasis MOA, regulatory milestones, product development activities, advantages, disadvantages, safety and efficacy, etc.?
• How many companies are developing therapies for the treatment of Phototherapies for Psoriasis?
• How many therapies are in-development by each company for Phototherapies for Psoriasis treatment?
• How many are emerging therapies in mid-stage, and late stage of development for Phototherapies for Psoriasis treatment?
• What are the key collaborations (Industry - Industry, Industry - Academia), Mergers and acquisitions, licensing activities related to the Phototherapies for Psoriasis therapies?
• What are the recent novel therapies, targets, mechanisms of action and technologies being developed to overcome the limitation of existing therapies?
• What are the clinical studies going on for Phototherapies for Psoriasis and their status?
• What are the current challenges faced in drug development?
• What are the key designations that have been granted for the emerging therapies for Phototherapies for Psoriasis?
• What are the global historical and forecasted market of Phototherapies for Psoriasis?

Reasons to Buy Phototherapies for Psoriasis Market Report

• The patient-based Phototherapies for Psoriasis market forecasting report will help in developing business strategies by understanding trends shaping and driving the Phototherapies for Psoriasis market
• To understand the future market competition in the Phototherapies for Psoriasis market and Insightful review of the key market drivers and barriers
• Organize sales and marketing efforts by identifying the best opportunities for Phototherapies for Psoriasis in the US, Europe (Germany, Spain, Italy, France, and the United Kingdom) and Japan
• Identification of strong upcoming players in the Phototherapies for Psoriasis drugs market will help in devising strategies that will help in getting ahead of competitors
• Organize sales and marketing efforts by identifying the best opportunities for Phototherapies for Psoriasis drugs market
• To understand the future market competition in the Phototherapies for Psoriasis drugs market

Stay updated with us for Recent Articles @ New DelveInsight Blogs